MedTrace Logo

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

NCT05073744 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 316

Last updated 2022-12-29

No results posted yet for this study

Summary

This randomized, positive control, multicentre trial is designed to compare the analgesic efficacy and safety of nalbuphine hydrochloride injection and morphine hydrochloride injection for perioperative tumor ablation.

Conditions

  • Nalbuphine Allergy
  • Ablation
  • Safety

Interventions

DRUG

Nalbuphine

Nalbuphine hydrochloride injection or morphine hydrochloride injection is used for perioperative tumor ablation

DRUG

Morphine

Morphine hydrochloride injection is used for perioperative tumor ablation

Sponsors & Collaborators

  • Zhongda Hospital

    lead OTHER

Principal Investigators

  • Gao-Jun Teng, MD · Zhongda Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-05
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05073744 on ClinicalTrials.gov